 Kronos Bio, Inc. NASDAQ:KRON COO Barbara Kosacz bought 5,250 shares of Kronos Bio stock in a transaction dated Wednesday, October 14th. The stock was purchased at an average cost of 19.00 per share, for a total transaction of 99,750.00. Following the completion of the acquisition, the chief operating officer now directly owns 614,600 shares of ... 